 Home > Active Ingredient News > Drugs Articles > Deck Pharma announced that the Phase I clinical trial application of ATG-101 (the first PD-L1/4-1BB double antibody) was approved in Australia for the treatment of solid tumors and non-Hodgkin’s lymphoma

Deck Pharma announced that the Phase I clinical trial application of ATG-101 (the first PD-L1/4-1BB double antibody) was approved in Australia for the treatment of solid tumors and non-Hodgkin’s lymphoma

 Last Update: 2021-07-28
 Source: Internet
 Author: User

Tags

model application

2 4 toxicity

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Shanghai, China and Hong Kong, July 20, 2021 – A leading biopharmaceutical company dedicated to the development and commercialization of the world’s first and/or best-in-class blood and innovative tumor therapies – Deqi Pharmaceutical Co.

ATG-101 is an innovative drug developed by Deqi Pharmaceutical’s R&D team and has global rights and interests.

ATG-101 is a new PD-L1/4-1BB bispecific antibody, which can block the immunosuppressive PD-L1/PD-1 binding and activate the 4-1BB costimulatory signal to activate the anti-tumor immune effect Cells, while enhancing the efficacy of drugs, enhance safety

"The entry of ATG-101 into the first human trial as scheduled is a key milestone in the development of Deqi Pharmaceuticals, which fully demonstrates our team's ability to promote preclinical research

About ATG-101

ATG-101 is a new PD-L1/4-1BB bispecific antibody that is being developed for the treatment of cancer

About Deqi Pharmaceutical

Deqi Pharmaceutical Co.

Forward-looking statement

The forward-looking statements made in this article only relate to events or information as of the date when the statement is made in this article

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best Price Isopropylbenzylamine Crystal CAS 102-97-6 N-Isopropylbenzylamine Fast Delivery 99% crystal chemicals

CAS No.: 102-97-6

Pharmacy Grade

$2-2.2/MT EXW

Pregabalin Crystal CAS 148553-50-8 Lyrica Powder 99.0% White Powder Mobelbiochem

CAS No.: 148553-50-8

Pharmacy Grade

$35.00/KG FOB

PTD-DBM 99% freeze dried powder cas1199495-15-2

CAS No.: 1199495-15-2

Pharmacy Grade

$3-3.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.